Bruce Klein, MD, has been awarded $108,146 for the Accelerator Program “Drk-1 Antifungal.” Through the Graduate School, funding for this award has been provided by the Wisconsin Alumni Research Foundation (WARF). The goals of this study are to use Drk1 as a drug target to identify potent, broadly active anti-fungal drugs, to develop a simple screen for compounds that act on Drk1 and kill fungi, to advance the compounds as drug leads, and to engage an industry partner in drug development.